These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. When to use cytotoxic drugs in rheumatoid arthritis. Decker JL; Healey LA Geriatrics; 1973 Jun; 28(6):103-6. PubMed ID: 4196788 [No Abstract] [Full Text] [Related]
14. [The use of immunosuppressive drugs in the treatment of rheumatoid arthritis]. Pascual Gómez E Med Clin (Barc); 1983 Oct; 81(12):540-4. PubMed ID: 6656371 [No Abstract] [Full Text] [Related]
15. Immunosuppressive agents in dermatology. An update. Dutz JP; Ho VC Dermatol Clin; 1998 Apr; 16(2):235-51. PubMed ID: 9589197 [TBL] [Abstract][Full Text] [Related]
17. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta). Matalon ST; Ornoy A; Lishner M Reprod Toxicol; 2004; 18(2):219-30. PubMed ID: 15019720 [No Abstract] [Full Text] [Related]
18. Disease-modifying agents and immunosuppressive drugs in the elderly. O'Callaghan JW; Brooks PM Clin Rheum Dis; 1986 Apr; 12(1):275-89. PubMed ID: 2872995 [TBL] [Abstract][Full Text] [Related]
19. [The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance]. Kahn MF; De Seze S Ann Med Interne (Paris); 1974; 125(6-7):497-506. PubMed ID: 4216281 [No Abstract] [Full Text] [Related]
20. Use of immunosuppressant drugs in nonneoplastic disease. Caldwell JR JFMA; 1974 May; 61(5):375-7. PubMed ID: 4275140 [No Abstract] [Full Text] [Related] [Next] [New Search]